| Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various … A Trialists' Collaboration Bmj 308 (6921), 81, 1994 | 13708* | 1994 |
| Prostaglandins and inflammation E Ricciotti, GA FitzGerald Arteriosclerosis, thrombosis, and vascular biology 31 (5), 986-1000, 2011 | 4678 | 2011 |
| The coxibs, selective inhibitors of cyclooxygenase-2 GA FitzGerald, C Patrono New England Journal of Medicine 345 (6), 433-442, 2001 | 2265 | 2001 |
| Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS KK Griendling, GA FitzGerald Circulation 108 (16), 1912-1916, 2003 | 2059* | 2003 |
| Cyclooxygenase inhibitors and the antiplatelet effects of aspirin F Catella-Lawson, MP Reilly, SC Kapoor, AJ Cucchiara, S DeMarco, ... New England Journal of Medicine 345 (25), 1809-1817, 2001 | 2031 | 2001 |
| Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy C Patrono, B Coller, GA FitzGerald, J Hirsh, G Roth Chest 126 (3), 234S-264S, 2004 | 1878* | 2004 |
| Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 BF McAdam, F Catella-Lawson, IA Mardini, S Kapoor, JA Lawson, ... Proceedings of the National Academy of Sciences 96 (1), 272-277, 1999 | 1686 | 1999 |
| Platelet activation in unstable coronary disease DJ Fitzgerald, L Roy, F Catella, GA FitzGerald New England Journal of Medicine 315 (16), 983-989, 1986 | 1474 | 1986 |
| Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities T Grosser, S Fries, GA FitzGerald The Journal of clinical investigation 116 (1), 4-15, 2006 | 1338 | 2006 |
| A functional genomics strategy reveals Rora as a component of the mammalian circadian clock TK Sato, S Panda, LJ Miraglia, TM Reyes, RD Rudic, P McNamara, ... Neuron 43 (4), 527-537, 2004 | 1322 | 2004 |
| Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis TE North, W Goessling, CR Walkley, C Lengerke, KR Kopani, AM Lord, ... Nature 447 (7147), 1007-1011, 2007 | 1297 | 2007 |
| Coxibs and cardiovascular disease GA FitzGerald New England Journal of Medicine 351 (17), 1709-1711, 2004 | 1272 | 2004 |
| BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis RD Rudic, P McNamara, AM Curtis, RC Boston, S Panda, JB Hogenesch, ... PLoS biology 2 (11), e377, 2004 | 1231 | 2004 |
| Role of prostacyclin in the cardiovascular response to thromboxane A2 Y Cheng, SC Austin, B Rocca, BH Koller, TM Coffman, T Grosser, ... Science 296 (5567), 539-541, 2002 | 1087 | 2002 |
| Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? MB Kadiiska, BC Gladen, DD Baird, D Germolec, LB Graham, CE Parker, ... Free Radical Biology and Medicine 38 (6), 698-710, 2005 | 957* | 2005 |
| Understanding multicellular function and disease with human tissue-specific networks CS Greene, A Krishnan, AK Wong, E Ricciotti, RA Zelaya, ... Nature genetics 47 (6), 569-576, 2015 | 911 | 2015 |
| Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment CD Funk, LB Funk, ME Kennedy, AS Pong, GA Fitzgerald The FASEB journal 5 (9), 2304-2312, 1991 | 826 | 1991 |
| Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids F Catella-Lawson, B McAdam, BW Morrison, S Kapoor, D Kujubu, L Antes, ... Journal of Pharmacology and Experimental Therapeutics 289 (2), 735-741, 1999 | 808 | 1999 |
| Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. GA FitzGerald, JA Oates, J Hawiger, RL Maas, LJ Roberts, JA Lawson, ... The Journal of clinical investigation 71 (3), 676-688, 1983 | 783 | 1983 |
| Modulation of oxidant stress in vivo in chronic cigarette smokers M Reilly, N Delanty, JA Lawson, GA FitzGerald Circulation 94 (1), 19-25, 1996 | 772 | 1996 |
Tilo GrosserBielefeld UniversityEmail verificata su itmat.upenn.edu